SFM
BIO icon

Systematic Financial Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Systematic Financial Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,436
Closed -$1.78M – 599
2016
Q2 		$1.78M Buy
12,436
+140
+1% +$20K 0.02% 414
2016
Q1 		$1.68M Buy
12,296
+85
+0.7% +$11.2K 0.02% 422
2015
Q4 		$1.69M Sell
12,211
-3,275
-21% -$454K 0.02% 421
2015
Q3 		$2.08M Sell
15,486
-1,510
-9% -$217K 0.02% 439
2015
Q2 		$2.56M Sell
16,996
-2,719
-14% -$389K 0.02% 397
2015
Q1 		$2.67M Buy
19,715
+1,225
+7% +$152K 0.02% 413
2014
Q4 		$2.23M Buy
+18,490
New +$2.13M 0.02% 520

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Systematic Financial Management's BIO Position: Q3 2016 in Review

Systematic Financial Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2016, closing a stake of 12,436 shares — an estimated $1.78M sold.

Systematic Financial Management first reported a position in BIO in Q4 2014 and held it in 7 quarters. The position peaked at $2.67M in Q1 2015. 241 funds tracked by Wall St. Rank hold BIO as of Q3 2016.

  • Systematic Financial Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2016 after selling out during the quarter.
  • Systematic Financial Management sold 12,436 Bio-Rad Laboratories Class A shares in Q3 2016, an estimated $1.78M.
  • Systematic Financial Management first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and held it in 7 quarters.
  • Systematic Financial Management's Bio-Rad Laboratories Class A position peaked at $2.67M in Q1 2015.
  • 241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2016.

Based on Systematic Financial Management's 13F filing for Q3 2016, filed 14 Nov 2016.